Boston Scientific | BSX - Sales Revenues

Stock Price
74.79
Daily Change
1.31 1.78%
Monthly
-20.05%
Yearly
-26.36%
Q1 Forecast
72.27

Boston Scientific reported $5.29B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
CONMED USD 373.2M 35.3M Dec/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
Danaher USD 6.84B 790M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Illumina USD 1.16B 80M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.92M 32.86M Dec/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
J&J USD 24.6B 610M Dec/2025
Masimo USD 371.5M 600K Sep/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025